Fluorescent carbon nanoparticles in cancer diagnostic and therapy systems
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F49777513%3A23640%2F24%3A43975706" target="_blank" >RIV/49777513:23640/24:43975706 - isvavai.cz</a>
Výsledek na webu
<a href="https://www.sciencedirect.com/science/article/abs/pii/B9780443135910000176" target="_blank" >https://www.sciencedirect.com/science/article/abs/pii/B9780443135910000176</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1016/B978-0-443-13591-0.00017-6" target="_blank" >10.1016/B978-0-443-13591-0.00017-6</a>
Alternativní jazyky
Jazyk výsledku
angličtina
Název v původním jazyce
Fluorescent carbon nanoparticles in cancer diagnostic and therapy systems
Popis výsledku v původním jazyce
Fluorescent carbon nanoparticles (FCNPs) have emerged as a promising class of nanomaterials for cancer theranostic, combining diagnostic and therapeutic capabilities into a single platform. These nanoparticles (NPs) possess unique optical properties, including tunable fluorescence emission, excellent photostability, and low cytotoxicity, making them attractive for bioimaging and sensing applications. Additionally, FCNPs can act as nanocarriers for delivering chemotherapeutic drugs, gene therapeutics, or photosensitizers for photodynamic therapy. This typical chapter comprehensively overviews the latest developments using FCNPs for cancer diagnosis and treatment. We discuss the various synthesis methods, surface functionalization strategies, and the mechanisms underlying their fluorescence behavior. The applications of FcnPs in cancer cell imaging, tumor targeting, and drug delivery are highlighted, focusing on their ability to enhance the specificity and efficacy of cancer treatment. Recent advances in developing multifunctional FCNPs for multimodal imaging, combined chemo-photodynamic therapy, and stimuli-responsive drug release have also been explored. Furthermore, the challenges and perspectives associated with the clinical translation of FCNPs-based theranostic systems, including biocompatibility, biodistribution, and clearance considerations were addressed. Overall, this chapter underscores the significant potential of FCNPs as versatile nanoplatforms for integrated cancer diagnosis and therapy, paving the way for personalized and targeted cancer management strategies.
Název v anglickém jazyce
Fluorescent carbon nanoparticles in cancer diagnostic and therapy systems
Popis výsledku anglicky
Fluorescent carbon nanoparticles (FCNPs) have emerged as a promising class of nanomaterials for cancer theranostic, combining diagnostic and therapeutic capabilities into a single platform. These nanoparticles (NPs) possess unique optical properties, including tunable fluorescence emission, excellent photostability, and low cytotoxicity, making them attractive for bioimaging and sensing applications. Additionally, FCNPs can act as nanocarriers for delivering chemotherapeutic drugs, gene therapeutics, or photosensitizers for photodynamic therapy. This typical chapter comprehensively overviews the latest developments using FCNPs for cancer diagnosis and treatment. We discuss the various synthesis methods, surface functionalization strategies, and the mechanisms underlying their fluorescence behavior. The applications of FcnPs in cancer cell imaging, tumor targeting, and drug delivery are highlighted, focusing on their ability to enhance the specificity and efficacy of cancer treatment. Recent advances in developing multifunctional FCNPs for multimodal imaging, combined chemo-photodynamic therapy, and stimuli-responsive drug release have also been explored. Furthermore, the challenges and perspectives associated with the clinical translation of FCNPs-based theranostic systems, including biocompatibility, biodistribution, and clearance considerations were addressed. Overall, this chapter underscores the significant potential of FCNPs as versatile nanoplatforms for integrated cancer diagnosis and therapy, paving the way for personalized and targeted cancer management strategies.
Klasifikace
Druh
C - Kapitola v odborné knize
CEP obor
—
OECD FORD obor
21001 - Nano-materials (production and properties)
Návaznosti výsledku
Projekt
—
Návaznosti
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Ostatní
Rok uplatnění
2024
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Údaje specifické pro druh výsledku
Název knihy nebo sborníku
Fluorescent Carbon Nanoparticles: Fundamentals and Applications
ISBN
978-0-443-13591-0
Počet stran výsledku
49
Strana od-do
367-415
Počet stran knihy
867
Název nakladatele
Elsevier
Místo vydání
Nizozemí
Kód UT WoS kapitoly
—